期刊
JOURNAL OF CHILD NEUROLOGY
卷 22, 期 8, 页码 952-956出版社
SAGE PUBLICATIONS INC
DOI: 10.1177/0883073807305668
关键词
spinal muscular atrophy; SMN1 gene; gene dosage testing; SMN2 gene
资金
- PHS HHS [174615] Funding Source: Medline
Spinal muscular atrophy is a common autosomal recessive neuromuscular disorder caused by mutations in the survival motor neuron gene (SMN), which exists in 2 nearly identical copies (SMN1 and SMN2). Exon 7 of SMN1 is homozygously absent in about 95% of spinal muscular atrophy patients, whereas the loss of SMN2 does not cause spinal muscular atrophy. Small mutations are found in the other 5% of affected patients, and these mutations cluster in the 3' end of SMN1 a region important for protein oligomerization. SJWN1 dosage testing can be used to determine the SMN1 copy number and to detect spinal muscular atrophy carriers and affected compound heterozygotes. Dosage testing is compromised by the presence of 2 SMN1 copies per chromosome, which occurs in about 2% of carriers. Finally, although SMN2 produces less full-length transcript than SMN1 the number of SMN2 copies modulates the phenotype.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据